Table 4.

The protective effect of HLJDT CFP, baicalin–berberine complex, and baicalin–berberine 1:1 mixture on injured PC12 cells. Data are expressed as means ± SD from three separate experiments.

Samples	Proliferation Rate (%)					EC50 (μg/mL)
	60 μg/mL	30 μg/mL	15 μg/mL	7.5 μg/mL	3.75 μg/mL
HLJDT CFP	85.08 ± 9.72	86.98 ± 10.03	96.79 ± 6.52	91.53 ± 7.58	85.58 ± 9.03	3.35 ± 1.11
Baicalin–Berberine complex	73.62 ± 7.96	74.17 ± 7.46	81.48 ± 6.08	75.10 ± 6.94	70.05 ± 8.72	5.79 ± 1.67
Baicalin–Berberine 1:1 mixture	70.45 ± 5.36	65.83 ± 5.85	59.43 ± 4.43	49.38 ± 6.57	44.57 ± 6.84	11.1 ± 2.49